BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4934830)

  • 21. Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease.
    Kerber RE; Goldman RH; Alderman EL; Harrison DC
    Am J Cardiol; 1972 Jan; 29(1):26-32. PubMed ID: 4399889
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemodynamic effects of glucagon after mitral valve replacement.
    Smith GH; Chandra K
    Thorax; 1972 Sep; 27(5):591-3. PubMed ID: 4563399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of glucagon.
    Westlie L; Andersen A; Jervell J; Rasmussen K; Storstein O
    Acta Med Scand; 1971 Mar; 189(3):179-84. PubMed ID: 5090202
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemodynamic effects of glucagon, isoprenaline and dopamine in patients with congestive circulatory insufficiency].
    Kukes VG; Tsoĭ AN; Iatsenko IV; Sivkov SI; Burian EF
    Kardiologiia; 1982 Sep; 22(9):62-6. PubMed ID: 7143898
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaerobiosis induced by isoproterenol and glucagon in the presence of restricted coronary inflow.
    Shaver JC; Lombardo AA; Shaver VC
    Am Heart J; 1974 Jan; 87(1):97-104. PubMed ID: 4808764
    [No Abstract]   [Full Text] [Related]  

  • 26. Systolic time intervals as measures of the contractile state of the left ventricular myocardium in man.
    Ahmed SS; Levinson GE; Schwartz CJ; Ettinger PO
    Circulation; 1972 Sep; 46(3):559-71. PubMed ID: 4561119
    [No Abstract]   [Full Text] [Related]  

  • 27. Failure of glucagon in experimental hemorrhagic shock.
    Madden JJ; Ludewig RM; Wangensteen SL
    Am J Surg; 1971 Oct; 122(4):502-4. PubMed ID: 5098655
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemodynamic effects of a combination of theophylline and ethylenediamine in heart failure with pulmonary hypertension].
    Klein W
    Arzneimittelforschung; 1969 Sep; 19(9):1559-62. PubMed ID: 5394532
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiac action of glucagon in patients with heart diseases].
    Hermann HJ; Sanmarco ME; Meyers SN
    Prensa Med Argent; 1971 Jul; 58(22):1079-85. PubMed ID: 5097750
    [No Abstract]   [Full Text] [Related]  

  • 30. Action of drugs in patients early after cardiac surgery. I. Comparison of isoproterenol and dopamine.
    Holloway EL; Stinson EB; Derby GC; Harrison DC
    Am J Cardiol; 1975 May; 35(5):656-9. PubMed ID: 1124720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous dopamine in the treatment of myocardial dysfunction after open-heart surgery.
    Rosenblum R; Frieden J
    Am Heart J; 1972 Jun; 83(6):743-8. PubMed ID: 5053143
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic and coronary hemodynamic effects of glucagon.
    Rowe GG
    Am J Cardiol; 1970 Jun; 25(6):670-4. PubMed ID: 5420906
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of intravenous morphine in patients with mitral valvular disease and congestive heart failure.
    Grendahl H; Andersen A; Müller C
    Acta Med Scand; 1973; 1-2(1):69-74. PubMed ID: 4727250
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of glucagon in animals on chronic propranolol therapy.
    Peterson A; Lucchesi B; Kirsh MM
    Ann Thorac Surg; 1978 Apr; 25(4):340-5. PubMed ID: 637610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac effects of isoproterenol during graded myocardial ischemia.
    Lekven J; Kjekshus JK; Mjös OD
    Scand J Clin Lab Invest; 1974 Apr; 33(2):161-71. PubMed ID: 4850884
    [No Abstract]   [Full Text] [Related]  

  • 37. Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog.
    Hopkins BE; Taylor RR
    J Clin Invest; 1974 Jun; 53(6):1716-25. PubMed ID: 4830233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved cardiovascular effects of glucagon in dogs with endotoxin shock.
    Guillen J; Pappas G
    Ann Surg; 1972 Apr; 175(4):535-8. PubMed ID: 5020669
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of glucagon on resting and exercise haemodynamics in patients with coronary heart disease.
    Greenberg BH; McCallister BD; Frye RL
    Br Heart J; 1972 Sep; 34(9):924-9. PubMed ID: 5075311
    [No Abstract]   [Full Text] [Related]  

  • 40. Nitrate therapy of heart failure in valvular heart disease. Importance of resting level of peripheral vascular resistance in determining cardiac output response.
    Goldberg S; Mann T; Grossman W
    Am J Med; 1978 Jul; 65(1):161-6. PubMed ID: 685988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.